Our Mission

VantAI's mission is to unlock a new chapter in medicine by making protein interactions programmable

Inducers

Modulators

Blockers

An Integrated Discovery Platform

Three complementary, phase shifting technologies…

…built to unlock the full potential of the proximity modulator modality

Working With Industry Leaders

BUILD THE FUTURE WITH US

Latest News

August 19, 2025
VantAI and Halda Therapeutics Forge Alliance to Discover Next-Generation RIPTAC Medicines
VantAI and Halda Therapeutics today announced a strategic research collaboration worth over $1 billion in total potential value.
May 20, 2025
VantAI Expands Strategic Collaboration with Blueprint Medicines to Advance Induced Proximity Drug Discovery
VantAI announced today that it has entered into a second expansion of its collaboration and license agreement with Blueprint Medicines.
March 21, 2025
VantAI Launches Neo-1
VantAI launches Neo-1, the first AI model to rewire molecular interactions by unifying structure prediction and generation for therapeutic design.

Generative AI in Drug Discovery Lecture Series

Dive into our premiere episodes of a monthly lecture series dedicated to Generative AI in Drug Discovery

About Us

If you are looking for a role at the bleeding edge of artificial intelligence, where your impact is immediate and meaningful, this is it.

Apply your skills to help us tackle some of the most complex and meaningful scientific challenges on the planet.